Drug:
Reaction: PRURITUS
20250101 - 20251231
No. 1201 - 1300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1201 | 25077527 |
US |
54 | 2 |
Pruritus, Rash, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1202 | 25077575 |
US |
57 | 1 |
Pruritus, Skin tightness, Pain of skin, Pigmentation disorder, Skin burning sensation, Insomnia, Injection site bruising, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 1203 | 25077797 |
CN |
64 | 1 |
Laryngeal oedema, Erythema, Urticaria, Pruritus, Drug hypersensitivity, Infusion related reaction, |
||||
DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 1204 | 25077850 |
US |
||
Systemic lupus erythematosus, Pruritus, Pain in extremity, Product administered at inappropriate site, Product dose omission issue, |
||||
BELIMUMAB, BELIMUMAB, BELIMUMAB, |
||||
| 1205 | 25077878 |
CA |
72 | 2 |
Arthritis, Fatigue, Feeling hot, Headache, Malignant melanoma, Nasopharyngitis, Pruritus, Rash, Scratch, Therapeutic product effect incomplete, Upper limb fracture, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, HYDROXYZINE, HYDROXYZINE PAMOATE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, POTASSIUM CHLORATE, POTASSIUM CHLORATE, PREDNISONE, SULFASALAZINE, |
||||
| 1206 | 25077901 |
CA |
77 | 2 |
Aortic aneurysm, Haemorrhage, Cardiac disorder, Heart rate increased, Hypertension, Peripheral swelling, Pruritus, Pyrexia, Scratch, Swelling, Urticaria, Wound secretion, Therapeutic product effect incomplete, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, |
||||
| 1207 | 25077964 |
US |
1 | |
Product dose omission in error, Constipation, Weight increased, Abdominal pain upper, Pruritus, Genital herpes, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AMLODIPINE BESYLATE, BRIMONIDINE TARTRATE, MAGNESIUM HYDROXIDE, POLYETHYLENE GLYCOL 3350, IRBESARTAN, MELOXICAM, TADALAFIL, SILDENAFIL CITRATE, ROSUVASTATIN CALCIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 1208 | 25078020 |
DE |
63 | 1 |
Hepatitis toxic, Malaise, Abdominal discomfort, Ocular icterus, Pruritus, Faeces pale, Jaundice, |
||||
ROSUVASTATIN, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, LOSARTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 1209 | 25078146 |
US |
2 | |
Fungal infection, Poor quality product administered, Product quality issue, Skin reaction, Hypersensitivity, Urticaria, Peripheral swelling, Pruritus, Rash, Vomiting, Nausea, |
||||
SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE, ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
| 1210 | 25078211 |
CA |
50 | 2 |
Abdominal discomfort, Abdominal pain upper, Anti-cyclic citrullinated peptide antibody positive, Asthenia, C-reactive protein abnormal, Condition aggravated, Contraindicated product administered, Contusion, Diarrhoea, Dyspnoea, Discomfort, Fibromyalgia, Frequent bowel movements, Hand deformity, Hepatic enzyme increased, Hypersensitivity, Infection, Insomnia, Joint range of motion decreased, Joint swelling, Lip dry, Liver disorder, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Lupus-like syndrome, Malaise, Medication error, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Night sweats, Obesity, Oedema, Oedema peripheral, Off label use, Osteoarthritis, Osteoporosis, Pain in extremity, Pancreatitis, Paraesthesia, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Rectal haemorrhage, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Weight decreased, Weight fluctuation, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, |
||||
| 1211 | 25078333 |
DE |
63 | 1 |
Hepatitis toxic, Abdominal discomfort, Ocular icterus, Malaise, Jaundice, Faeces pale, Pruritus, |
||||
LOSARTAN, ROSUVASTATIN, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 1212 | 25078353 |
CA |
35 | 2 |
Anxiety, Asthma, Burning sensation, Chest discomfort, Chest pain, Cough, Crying, Dehydration, Depression, Dizziness, Dyspnoea, Emphysema, Feeling cold, Fluid retention, Forced expiratory volume decreased, Hot flush, Hypoventilation, Illness, Injection site pain, Lower respiratory tract infection, Malaise, Influenza, Mental disorder, Nasal congestion, Nasopharyngitis, Nausea, Obstructive airways disorder, Oropharyngeal pain, Pain, Pain in extremity, Peripheral swelling, Pneumonia, Productive cough, Pruritus, Rhinorrhoea, Seasonal allergy, Stress, Suicidal ideation, Syncope, Vomiting, Weight decreased, Weight increased, Wheezing, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, QUETIAPINE FUMARATE, QUETIAPINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, |
||||
| 1213 | 25078384 |
US |
54 | 1 |
Erythema, Pruritus, Skin burning sensation, |
||||
ABATACEPT, |
||||
| 1214 | 25078470 |
US |
50 | 2 |
Pruritus, Off label use, |
||||
PALBOCICLIB, |
||||
| 1215 | 25078537 |
PT |
77 | 1 |
Macule, Pruritus, |
||||
APALUTAMIDE, GABAPENTIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BISOPROLOL FUMARATE, NIFEDIPINE, EMPAGLIFLOZIN, |
||||
| 1216 | 25078591 |
US |
65 | 2 |
Pruritus, Inappropriate schedule of product administration, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1217 | 25078607 |
US |
84 | 1 |
Rebound eczema, Pruritus, Paraesthesia, Therapeutic response decreased, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1218 | 25078615 |
US |
1 | |
Eczema, Pruritus, Insomnia, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1219 | 25078618 |
US |
69 | 1 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1220 | 25078629 |
US |
64 | 2 |
Dry skin, Skin haemorrhage, Blister, Illness, Pruritus, Injection site pain, Dry eye, Drug ineffective, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1221 | 25078638 |
US |
20 | 1 |
Dry skin, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, |
||||
| 1222 | 25078642 |
US |
1 | |
Pruritus, Injection site erythema, Injection site swelling, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, EVOLOCUMAB, |
||||
| 1223 | 25078686 |
US |
2 | |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 1224 | 25078691 |
US |
22 | 1 |
Eczema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1225 | 25078791 |
US |
23 | 2 |
Pruritus, Dry skin, Skin exfoliation, Skin haemorrhage, Skin weeping, Skin fissures, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 1226 | 25078911 |
US |
75 | 1 |
Pruritus, |
||||
LENALIDOMIDE, |
||||
| 1227 | 25078989 |
US |
38 | 2 |
Lymphoproliferative disorder, Pruritus, Skin plaque, |
||||
PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, ETOPOSIDE, |
||||
| 1228 | 25079306 |
CO |
64 | 2 |
Anaphylactic shock, Pruritus, Rash, Dyspnoea, Hypoperfusion, Hypotension, |
||||
IOPROMIDE, |
||||
| 1229 | 25079407 |
US |
51 | 2 |
Blindness unilateral, Paraesthesia, Hot flush, Eye swelling, Erythema, Pruritus, Pain, Conjunctivitis, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1230 | 25079529 |
US |
31 | 1 |
Pruritus, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, |
||||
| 1231 | 25079668 |
US |
74 | 2 |
Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, ALPRAZOLAM, TIZANIDINE HYDROCHLORIDE, MUPIROCIN, MUPIROCIN CALCIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATENOLOL, LOSARTAN POTASSIUM, LOSARTAN, GLIMEPIRIDE, OLANZAPINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 1232 | 25079754 |
US |
28 | 2 |
Product complaint, Accidental exposure to product, Pruritus, Swelling face, |
||||
OMALIZUMAB, |
||||
| 1233 | 25079907 |
FR |
74 | 2 |
Type I hypersensitivity, Urticaria, Allergy test positive, Pruritus, Malaise, |
||||
AMOXICILLIN, TRAMADOL HYDROCHLORIDE, |
||||
| 1234 | 25080060 |
CN |
56 | 2 |
Rash, Pruritus, |
||||
OMADACYCLINE, OMADACYCLINE, |
||||
| 1235 | 25085629 |
19 | 1 | |
Urticaria, Pruritus, Infusion related reaction, |
||||
HUMAN IMMUNOGLOBULIN G, |
||||
| 1236 | 25085631 |
19 | 1 | |
Urticaria, Pruritus, Infusion related reaction, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 1237 | 25071645 |
CN |
74 | |
Pruritus, Rash, Poor quality sleep, |
||||
CARBOPLATIN, CARBOPLATIN, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, |
||||
| 1238 | 25071771 |
US |
77 | 2 |
Pruritus, Illness, Hypoacusis, Product substitution issue, |
||||
VALSARTAN AND HYDROCHLOROTHIAZIDE, |
||||
| 1239 | 25071819 |
US |
43 | 2 |
Condition aggravated, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1240 | 25071820 |
US |
64 | 2 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1241 | 25071822 |
US |
58 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 1242 | 25071823 |
US |
2 | |
Dry skin, Pruritus, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 1243 | 25071830 |
US |
20 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1244 | 25071834 |
US |
2 | |
Pruritus, Rash, Product dose omission issue, |
||||
DUPILUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FUROSEMIDE, GABAPENTIN, ISOSORBIDE DINITRATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, NIFEDIPINE, HUMAN INSULIN, PANTOPRAZOLE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TIOTROPIUM BROMIDE, VITAMIN A, |
||||
| 1245 | 25071873 |
US |
35 | 1 |
Dermatitis, Eczema, Pruritus, Erythema, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1246 | 25071887 |
US |
75 | 2 |
Sleep disorder due to a general medical condition, Dry skin, Blood calcium decreased, Renal disorder, Pruritus, |
||||
DUPILUMAB, |
||||
| 1247 | 25071987 |
US |
1 | |
Dry skin, Pruritus, |
||||
DUPILUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 1248 | 25072061 |
US |
1 | |
Pruritus, Fatigue, |
||||
PEXIDARTINIB HYDROCHLORIDE, |
||||
| 1249 | 25072079 |
US |
1 | |
Pruritus, Eye pruritus, |
||||
DUPILUMAB, |
||||
| 1250 | 25072088 |
US |
66 | 1 |
Haemorrhage, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1251 | 25072093 |
US |
75 | 1 |
Drug intolerance, Pruritus, Rash, Drug ineffective, |
||||
DUPILUMAB, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, LINACLOTIDE, TAMSULOSIN HYDROCHLORIDE, ALLOPURINOL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, APIXABAN, |
||||
| 1252 | 25072094 |
US |
2 | |
Pruritus, |
||||
DUPILUMAB, |
||||
| 1253 | 25072158 |
US |
67 | 2 |
Weight decreased, Weight increased, Pruritus, |
||||
TOCILIZUMAB, |
||||
| 1254 | 25072179 |
US |
58 | 2 |
Alopecia, Eczema, Pruritus, Erythema, Skin exfoliation, Skin haemorrhage, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1255 | 25072194 |
ES |
58 | 1 |
Erythema, Malaise, Face oedema, Urticaria, Pruritus, |
||||
ROSUVASTATIN, |
||||
| 1256 | 25072221 |
US |
13 | 2 |
Alopecia, Eczema, Erythema, Pruritus, Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1257 | 25072273 |
US |
65 | 1 |
Product dose omission issue, Accidental exposure to product, Wrong technique in device usage process, Drug ineffective, Device malfunction, Syringe issue, Pruritus, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, ALPRAZOLAM, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, MONTELUKAST, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 1258 | 25072277 |
US |
31 | 2 |
Retching, Myalgia, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1259 | 25072292 |
US |
83 | 1 |
Urticaria, Dermatitis atopic, Pruritus, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1260 | 25072359 |
US |
69 | 2 |
Pruritus, Erythema, |
||||
SARILUMAB, |
||||
| 1261 | 25072361 |
US |
69 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 1262 | 25072362 |
US |
20 | 1 |
Dry skin, Skin exfoliation, Skin haemorrhage, Skin weeping, Skin fissures, Pruritus, |
||||
DUPILUMAB, |
||||
| 1263 | 25072466 |
US |
56 | 2 |
Tunnel vision, Photophobia, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 1264 | 25072543 |
US |
44 | 1 |
Headache, Pruritus, Erythema, |
||||
| 1265 | 25072560 |
US |
21 | 1 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1266 | 25072652 |
US |
56 | 2 |
Pain, Pruritus, |
||||
DUPILUMAB, |
||||
| 1267 | 25072688 |
US |
85 | 2 |
Ear haemorrhage, Pruritus, |
||||
DUPILUMAB, |
||||
| 1268 | 25072843 |
US |
78 | 2 |
Pruritus, |
||||
TRALOKINUMAB-LDRM, |
||||
| 1269 | 25072858 |
US |
2 | 2 |
Sleep disorder, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 1270 | 25072925 |
US |
39 | 1 |
Pruritus, Urticaria, Rash, |
||||
DUPILUMAB, |
||||
| 1271 | 25072995 |
US |
27 | 2 |
Dry skin, Pruritus, Skin exfoliation, Injection site pain, Product preparation error, |
||||
DUPILUMAB, |
||||
| 1272 | 25073039 |
CN |
59 | 2 |
Erythema induratum, Pruritus, Induration, Off label use, |
||||
| 1273 | 25073052 |
US |
34 | 2 |
Skin fissures, Pruritus, Dry skin, Skin exfoliation, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
| 1274 | 25073074 |
US |
2 | |
Neurodermatitis, Pruritus, Pain, Skin wound, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1275 | 25073082 |
US |
2 | |
Gastrointestinal disorder, Pruritus, |
||||
ADALIMUMAB, |
||||
| 1276 | 25073096 |
US |
71 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 1277 | 25073128 |
CA |
49 | 2 |
Constipation, Erythema, Eye irritation, Eye pain, Eye pruritus, Eye swelling, Hypoaesthesia, Lip swelling, Pruritus, Rash macular, Swelling, Swelling face, Angioedema, Fatigue, Headache, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 1278 | 25073129 |
US |
73 | 2 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1279 | 25073311 |
US |
36 | 1 |
Rash erythematous, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1280 | 25073367 |
US |
61 | 1 |
Pruritus, Pain, |
||||
TRALOKINUMAB-LDRM, |
||||
| 1281 | 25073381 |
US |
41 | 2 |
Faeces discoloured, Dehydration, Asthenia, Off label use, Generalised oedema, Pharyngeal swelling, Pruritus, Burning sensation, Dyspnoea, Abdominal pain, Panic attack, |
||||
| 1282 | 25073400 |
US |
||
Eye pruritus, Pruritus, |
||||
TIRZEPATIDE, |
||||
| 1283 | 25073429 |
US |
19 | 1 |
Dermatitis atopic, Pruritus, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1284 | 25073503 |
US |
62 | 2 |
Breast pain, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1285 | 25073512 |
CA |
||
Abdominal pain upper, Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Fatigue, Fluid retention, Fibromyalgia, Folliculitis, Gait disturbance, Gastrointestinal disorder, Gait inability, General physical health deterioration, General symptom, Grip strength decreased, Glossodynia, Hand deformity, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriatic arthropathy, Psoriasis, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid factor positive, Rheumatoid arthritis, Sleep disorder, Sinusitis, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Type 2 diabetes mellitus, Systemic lupus erythematosus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, X-ray abnormal, Wound infection, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, IODINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CALCIUM, ERGOCALCIFEROL, LANSOPRAZOLE, LISINOPRIL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, SULFASALAZINE, FISH OIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, LORAZEPAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 1286 | 25073568 |
US |
||
Pruritus, |
||||
GOLIMUMAB, |
||||
| 1287 | 25073593 |
CA |
26 | 2 |
Urticaria, Anaphylactic reaction, Angioedema, Blood pressure increased, COVID-19, Condition aggravated, Contusion, Cough, Erythema, Fatigue, Headache, Heart rate increased, Illness, Immunodeficiency, Injection site pain, Insomnia, Ligament sprain, Loss of consciousness, Malaise, Menstrual disorder, Migraine, Musculoskeletal stiffness, Nasopharyngitis, Obstructive airways disorder, Off label use, Oropharyngeal pain, Pain, Peripheral swelling, Pharyngitis streptococcal, Pruritus, Respiratory arrest, Sensitivity to weather change, Sinus congestion, Sinusitis, Skin burning sensation, Sleep apnoea syndrome, Stress, Swelling, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DUPILUMAB, GABAPENTIN, MEDROXYPROGESTERONE ACETATE, PREDNISONE, BUPROPION HYDROCHLORIDE, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, |
||||
| 1288 | 25073622 |
US |
||
Withdrawal syndrome, Pruritus, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 1289 | 25073657 |
US |
84 | 2 |
Pruritus, Rash, Injection site pain, |
||||
DUPILUMAB, |
||||
| 1290 | 25073696 |
US |
||
Dyspnoea, Wheezing, Palpitations, Dysphagia, Tinnitus, Pruritus, Confusional state, Dizziness, Headache, Hypoaesthesia oral, Drug ineffective, |
||||
BENZONATATE, |
||||
| 1291 | 25073710 |
US |
1 | |
Off label use, Malaise, Arthralgia, Sleep disorder due to a general medical condition, Pruritus, Chills, Asthenia, Neck pain, Back pain, |
||||
APREMILAST, APREMILAST, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 1292 | 25073725 |
US |
46 | 1 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 1293 | 25073966 |
CA |
53 | 2 |
Asthenia, Asthma, Bladder pain, Blood pressure fluctuation, Blood pressure increased, Blood thyroid stimulating hormone increased, Bronchitis, Cataract, Concussion, Condition aggravated, Cough, Dizziness, Dyspnoea, Ear discomfort, Eye pruritus, Fall, Fatigue, Feeling hot, Gait disturbance, Gastroenteritis, Head banging, Headache, Hypersensitivity, Hypertension, Inappropriate schedule of product administration, Influenza, Lymphadenitis, Lymphadenopathy, Migraine, Mood altered, Nasal pruritus, Nasopharyngitis, Neck pain, Oral pruritus, Paraesthesia, Pneumonitis, Pruritus, Respiratory disorder, Respiratory syncytial virus infection, Respiratory tract congestion, Retinal tear, Salivary hypersecretion, Sensitivity to weather change, Sinusitis, Sneezing, Somnolence, Stress, Swelling, Swelling face, Throat irritation, Thyroid mass, Wound infection fungal, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, DIPHENHYDRAMINE HYDROCHLORIDE, CANDESARTAN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, TERBINAFINE HYDROCHLORIDE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 1294 | 25073971 |
US |
2 | |
Hospitalisation, Urticaria, Pruritus, Drug hypersensitivity, |
||||
LEVONORGESTREL, |
||||
| 1295 | 25073977 |
CA |
||
Arthralgia, Pruritus, Skin burning sensation, Shock, Pustule, Mental disorder, Aphonia, Product dose omission issue, Myalgia, Alopecia, Back pain, Ligament sprain, Injection site pain, Pain, General physical condition abnormal, Influenza, Pain in extremity, Peripheral swelling, Burning sensation, Nausea, Weight increased, Diarrhoea, Somnolence, Urticaria, Blood pressure systolic increased, Fatigue, Bronchitis, COVID-19, Erythema, Feeling abnormal, Gait inability, Ill-defined disorder, Insomnia, Musculoskeletal stiffness, Osteoarthritis, Pyrexia, Skin plaque, Therapy partial responder, Swelling, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, LORAZEPAM, LORAZEPAM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, TIMOLOL, |
||||
| 1296 | 25074031 |
GB |
46 | 2 |
Haematochezia, Pruritus genital, Retinal migraine, Migraine, Anal pruritus, Lichen planus, Genital rash, Mucous stools, Rash, Pruritus, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 1297 | 25074105 |
US |
33 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 1298 | 25074107 |
US |
66 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 1299 | 25074111 |
US |
42 | 2 |
Erythema, Skin exfoliation, Pruritus, Injection site pruritus, Injection site haemorrhage, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1300 | 25074150 |
US |
53 | 2 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28